cisapride has been researched along with Hepatitis C in 1 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
Hepatitis C: INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gastric emptying in 14 patients with chronic hepatitis C was estimated by the sulfamethizole capsule method before and 1 and 2 weeks after the beginning of interferon-alpha (6 million U/day) therapy." | 7.69 | Delayed gastric emptying during interferon-alpha therapy in patients with chronic hepatitis C: relief by cisapride. ( Kanayama, S; Kawata, S; Matsuzawa, Y; Nishibayashi, H; Shinomura, Y, 1997) |
| "Gastric emptying in 14 patients with chronic hepatitis C was estimated by the sulfamethizole capsule method before and 1 and 2 weeks after the beginning of interferon-alpha (6 million U/day) therapy." | 3.69 | Delayed gastric emptying during interferon-alpha therapy in patients with chronic hepatitis C: relief by cisapride. ( Kanayama, S; Kawata, S; Matsuzawa, Y; Nishibayashi, H; Shinomura, Y, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nishibayashi, H | 1 |
| Kanayama, S | 1 |
| Shinomura, Y | 1 |
| Kawata, S | 1 |
| Matsuzawa, Y | 1 |
1 other study available for cisapride and Hepatitis C
| Article | Year |
|---|---|
Delayed gastric emptying during interferon-alpha therapy in patients with chronic hepatitis C: relief by cisapride.
Topics: Antiviral Agents; Cisapride; Dyspepsia; Female; Gastric Emptying; Gastrointestinal Agents; Hepatitis | 1997 |